scholarly article | Q13442814 |
P356 | DOI | 10.1212/WNL.0B013E3182918C6F |
P698 | PubMed publication ID | 23576622 |
P50 | author | Maria Pia Amato | Q56451881 |
Nicola De Stefano | Q56811273 | ||
Emilio Portaccio | Q87057500 | ||
Benedetta Goretti | Q114425902 | ||
P2093 | author name string | Francesca Rossi | |
Antonio Giorgio | |||
Bahia Hakiki | |||
Maria Laura Stromillo | |||
Lorenzo Razzolini | |||
Luisa Pastò | |||
Marta Giannini | |||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 1728-1733 | |
P577 | publication date | 2013-04-10 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study | |
P478 | volume | 80 |
Q47872883 | "Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary. |
Q47872908 | "Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - YES. |
Q35747637 | A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity |
Q35809567 | A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients |
Q48901292 | A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients |
Q88575184 | A simple measure of cognitive reserve is relevant for cognitive performance in MS patients |
Q38798954 | A useful annual review of cognition in relapsing MS is beyond most neurologists - Commentary |
Q43920338 | Active cognitive reserve influences the regional atrophy to cognition link in multiple sclerosis |
Q40542938 | Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes |
Q90220327 | Aging with multiple sclerosis: prevalence and profile of cognitive impairment |
Q31070072 | Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact |
Q33672609 | Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS. |
Q38481083 | Cerebral small vessel disease, cognitive reserve and cognitive dysfunction |
Q30889903 | Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis |
Q30738659 | Clinical relevance of brain volume measures in multiple sclerosis |
Q26782847 | Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis |
Q88687897 | Cognitive assessment in multiple sclerosis-an Italian consensus |
Q39216937 | Cognitive dysfunction in early multiple sclerosis: a review |
Q62719539 | Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures |
Q38125166 | Cognitive reserve in multiple sclerosis |
Q40967590 | Cognitive reserve in multiple sclerosis: Protective effects of education. |
Q48204718 | Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis |
Q47882340 | Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study. |
Q48625365 | Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS. |
Q33928540 | Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis |
Q38942624 | Differential diagnosis, discerning depression from cognition |
Q50609733 | Differential effects of aging on motor and cognitive functioning in multiple sclerosis. |
Q35159288 | Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study |
Q37736791 | Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients |
Q37196556 | Environmental enrichment may protect against hippocampal atrophy in the chronic stages of traumatic brain injury |
Q48625940 | Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study |
Q38238548 | Fostering adherence to injectable disease-modifying therapies in multiple sclerosis |
Q37521539 | Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis |
Q42678160 | Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis. |
Q36734829 | Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis. |
Q38840386 | Information processing speed in multiple sclerosis: Past, present, and future |
Q58795499 | Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions |
Q48444465 | Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy |
Q57464024 | Learning ability correlates with brain atrophy and disability progression in RRMS |
Q38964699 | Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions |
Q48704199 | Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome |
Q48128231 | Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis |
Q38806628 | Measurement and maintenance of reserve in multiple sclerosis |
Q30926815 | Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough |
Q39460844 | Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom |
Q57285404 | Recommendations for cognitive screening and management in multiple sclerosis care |
Q38625426 | Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review |
Q42394516 | Reserve and Reserve-building activities research: key challenges and future directions |
Q50133393 | Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis |
Q37048758 | The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis |
Search more.